Search Results Search Sort by RelevanceMost Recent Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411. Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411. In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411. Medical Education Nov 2004 Research Ethics and Medical Education Stephen B. Leapman, MD and Sharon M. Moe, MD Virtual Mentor. 2004;6(11):494-496. doi: 10.1001/virtualmentor.2004.6.11.medu1-0411. Policy Forum Dec 2004 Achieving Diversity and Its Benefits in Clinical Research Vivian W. Pinn, MD Virtual Mentor. 2004;6(12):561-565. doi: 10.1001/virtualmentor.2004.6.12.pfor2-0412. Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411. Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411. In the Literature May 2004 Human Subjects Research for Biochemical Antidotes Susanna Smith Virtual Mentor. 2004;6(5):211-214. doi: 10.1001/virtualmentor.2004.6.5.jdsc1-0405. Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608. Pagination First page « First Previous page ‹ Previous … Page 5 Page 6 Page 7 Page 8 Current page 9 Page 10 Page 11 Page 12 Page 13 … Next page Next › Last page Last »
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 1 Charles Weijer, MD, PhD Virtual Mentor. 2004;6(11):482-484. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Heads or Tails: Randomized Placebo-Controlled Trials, Commentary 2 Karen Kreiner, MD Virtual Mentor. 2004;6(11):484-485. doi: 10.1001/virtualmentor.2004.6.11.ccas2-0411.
Case and Commentary Nov 2004 Who Is That? Expanding the Clinical Encounter Vijaya Arekapudi, MD Virtual Mentor. 2004;6(11):486-487. doi: 10.1001/virtualmentor.2004.6.11.ccas3-0411.
In the Literature Nov 2004 Maintaining Integrity in Industry-Sponsored Research Alison Bickford Virtual Mentor. 2004;6(11):490-493. doi: 10.1001/virtualmentor.2004.6.11.jdsc2-0411.
Medical Education Nov 2004 Research Ethics and Medical Education Stephen B. Leapman, MD and Sharon M. Moe, MD Virtual Mentor. 2004;6(11):494-496. doi: 10.1001/virtualmentor.2004.6.11.medu1-0411.
Policy Forum Dec 2004 Achieving Diversity and Its Benefits in Clinical Research Vivian W. Pinn, MD Virtual Mentor. 2004;6(12):561-565. doi: 10.1001/virtualmentor.2004.6.12.pfor2-0412.
Health Law Nov 2004 Wright v. Fred Hutchinson Cancer Center: Maintaining Patient and Public Trust in Clinical Research Laura Lin, MBA and Bryan A. Liang, MD, PhD, JD Virtual Mentor. 2004;6(11):501-504. doi: 10.1001/virtualmentor.2004.6.11.hlaw1-0411.
Policy Forum Nov 2004 Genetic Samples and Genetic Philanthropy Michael E. Berens, PhD and Gary E. Marchant, PhD, JD Virtual Mentor. 2004;6(11):509-511. doi: 10.1001/virtualmentor.2004.6.11.pfor2-0411.
In the Literature May 2004 Human Subjects Research for Biochemical Antidotes Susanna Smith Virtual Mentor. 2004;6(5):211-214. doi: 10.1001/virtualmentor.2004.6.5.jdsc1-0405.
Case and Commentary Nov 2016 Requests for VIP Treatment in Pathology: Implications for Social Justice and Systems-Based Practice Virginia Sheffield and Lauren B. Smith, MD Preferential treatment of “very important” patients is not only unjust but also can compromise patient safety, which is overlooked in medical ethics. AMA J Ethics. 2016;18(8):786-792. doi: 10.1001/journalofethics.2016.18.8.ecas4-1608.